EUVIMEDEUVIMED entdecken
Open Access

Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act

Deborah Cragun, Anne Weidner, Joy Kechik, Tuya Pal

Genetic Testing and Molecular Biomarkers · 2019-02 · 23 (2) · 75-83

DOI: 10.1089/gtmb.2018.0253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, online erschienen am 08.02.2019. Verfasst von Deborah Cragun und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study compared facilitators and barriers to genetic testing and determined awareness about the Genetic Information Nondiscrimination Act (GINA) across young Hispanic and non-Hispanic white (NHW) breast cancer (BC) survivors. Materials and Methods: Women diagnosed with BC of age ≤50 years in 2009-2012 were recruited through the Florida State Cancer Registry to complete a questionnaire.

Results

There were 1182 participants of which 61% (174/285) of Hispanic patients, and 65% (580/897) of NHW patients had BC testing. Among untested participants, the most common barriers were lack of testing recommendation (44% Hispanics, 32% NHW; p = 0.02) and cost-related concerns (41% Hispanics, 40% NHW; p = 0.83). Among tested participants, the top facilitators were as follows: (1) “To benefit my family's future” (70% Hispanic, 68% NHW), (2) “My doctor recommended testing” (60% Hispanic, 54% NHW), and (3) “Minimal cost to me” (59% Hispanic, 72% NHW). Only 27% of tested and 15% of untested women were aware of GINA; misuse of test results was reported as a barrier for only 6.5%.

Conclusions

Rates of genetic testing recommendation are lower among Hispanics, but both groups reported additional barriers. Most are unaware of GINA, yet misuse is not a highly cited barrier. Findings suggest the need to educate providers on the importance of recommending testing to all who meet criteria; increase awareness of newer options for more affordable testing; and bolster facilitators that may increase testing uptake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultBreast NeoplasmsCancer SurvivorsCommunication BarriersEthnicityFemaleFloridaGenetic TestingHealth Knowledge, Attitudes, PracticeHispanic or LatinoHumansMiddle AgedRisk FactorsSocioeconomic FactorsSurvivorsWhite People

Stichwörter der Autor:innen

GINA awarenessaccessbarriers and facilitatorsgenetic testinghereditary breast and ovarian cancer

Autor:innen und Institutionen

  • 1 Department of Global Health, College of Public Health, University of South Florida, Tampa, Florida.
  • 2 Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
  • 3 Vanderbilt University Medical Center, Department of Medicine, Division of Genetic Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

Förderung

  • NCI NIH HHS

Zitieren

APA

Cragun, D., Weidner, A., Kechik, J., & Pal, T. (2019). Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act. Genetic Testing and Molecular Biomarkers, 23(2), 75-83. https://doi.org/10.1089/gtmb.2018.0253

Vancouver

Cragun D, Weidner A, Kechik J, Pal T. Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act. Genetic Testing and Molecular Biomarkers. 2019;23(2):75-83. doi:10.1089/gtmb.2018.0253

BibTeX
@article{Cragun2019,
  author = {Cragun, Deborah and Weidner, Anne and Kechik, Joy and Pal, Tuya},
  title = {Genetic Testing Across Young Hispanic and Non-Hispanic White Breast Cancer Survivors: Facilitators, Barriers, and Awareness of the Genetic Information Nondiscrimination Act},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2019},
  volume = {23},
  number = {2},
  pages = {75--83},
  doi = {10.1089/gtmb.2018.0253}
}
Kostenlos starten →